Skip to main content

Xtant Medical Holdings, Inc.

XTNT
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001453593

No open-market purchases or sales by Xtant Medical Holdings, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $33.8M in total; no superinvestor holds it.

Holders of 5% or more of XTNT

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Xtant Medical Holdings, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of XTNT
HolderLatest formStakeChangeFirst filedLatest filingFiling
Nantahala Capital Management, LLC13D/A49.10%68.4M shares0.00 ppfrom 49.10%Nov 14, 20243 filingsAug 5, 2025SEC
Lytton Laurence W13G/A6.50%9.18M shares+1.00 ppfrom 5.50%Apr 16, 20253 filingsNov 16, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

19 Schedule 13D and 13G filings on Xtant Medical Holdings, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on XTNT
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 16, 20265:29 PM ETLytton Laurence Wand 1 other13G/A6.50%9.18M shares+1.00 ppfrom 5.50%Sep 30, 2026SEC
Feb 17, 202612:57 PM ETLytton Laurence Wand 1 other13G/A5.50%7.70M shares−1.30 ppfrom 6.80%Dec 31, 2025SEC
Aug 5, 20254:30 PM ETNantahala Capital Management, LLCand 3 others13D/A49.10%68.4M shares0.00 ppfrom 49.10%Aug 1, 2025SEC
Apr 17, 20254:31 PM ETNantahala Capital Management, LLCand 3 others13D49.10%68.4M shares+40.89 ppfrom 8.21%Apr 10, 2025SEC
Apr 16, 20252:11 PM ETLytton Laurence W13G6.80%9.46M sharesNewApr 15, 2025SEC
Apr 14, 20257:09 PM ETOrbiMed Advisors LLCand 1 other13D/A0.00%0 shares–Below 5%Apr 10, 2025SEC
Nov 14, 20244:53 PM ETNantahala Capital Management, LLCand 2 others13G8.21%11.4M sharesNewSep 30, 2024SEC
Sep 10, 2024OrbiMed Advisors LLC13D/AOld format–––SEC
Feb 13, 2024Altium Capital Management LP13G/AOld format–––SEC
Aug 3, 2023OrbiMed Advisors LLC13D/AOld format–––SEC
May 5, 2023OrbiMed Advisors LLC13D/AOld format–––SEC
Feb 14, 2023Altium Capital Management LP13G/AOld format–––SEC
Sep 6, 2022Vizirgianakis Stavros G.13DOld format–New–SEC
Aug 30, 2022OrbiMed Advisors LLC13D/AOld format–––SEC
Feb 14, 2022Altium Capital Management LP13G/AOld format–––SEC
Apr 9, 2021OrbiMed Advisors LLC13D/AOld format–––SEC
Mar 8, 2021Altium Capital Management LP13GOld format–New–SEC
Feb 26, 2021OrbiMed Advisors LLC13D/AOld format–––SEC
Feb 16, 2021Park West Asset Management LLC13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Xtant Medical Holdings, Inc. shares.

No Form 144 notices for Xtant Medical Holdings, Inc. are on file.